Skip to main content
Top
Published in: Journal of Nephrology 6/2015

Open Access 01-12-2015 | Original Article

Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease

Authors: Domenico Russo, Luigi Morrone, Biagio Di Iorio, Michele Andreucci, Maria Grazia De Gregorio, Carmela Errichiello, Luigi Russo, Francesco Locatelli

Published in: Journal of Nephrology | Issue 6/2015

Login to get access

Abstract

Background

Parathyroid hormone (PTH) has been associated with anemia only in dialysis patients with severe hyperparathyroidism. Whether an association between PTH and hemoglobin also exists in patients with chronic kidney disease not on dialysis (CKD-patients) is still unclear. In this study we evaluated the association between PTH and hemoglobin in CKD-patients without severe secondary hyperparathyroidism.

Methods

Hospitalized patients and outpatients (N = 979) were retrospectively evaluated and categorized according to PTH quartile and serum hemoglobin (<12.0, <11.0, <10.0 g/dl). Gender, diabetes, glomerular filtration rate (GFR), hemoglobin, PTH, markers of mineral metabolism, inflammation, iron status and nutrition were variables of adjustment in univariate and multivariate analysis.

Results

An inverse association (p = 0.001) was observed between PTH and hemoglobin in patients as a whole, in diabetics, and in patients with GFR ≤60 ml/min. PTH was the single predictor of low hemoglobin in patients as a whole (unstandardized beta −2.12; p = 0.005), in diabetics (unstandardized beta −8.86; p = 0.007) and in patients with GFR ≤60 ml/min (unstandardized beta −2.52; p = 0.006). For each increase of quartile of PTH the risk of having hemoglobin level <10.0 mg/dl was more than doubled [hazard ratio (HR) 2.79, 95 % confidence interval (CI) 2.00–3.88; p = 0.001]. The receiver operating characteristic curve showed that PTH ≥122 pg/ml had 67 % sensitivity and 75 % specificity in predicting hemoglobin level <10.0 g/dl with area under the curve of 0.758 (95 % CI 0.73–0.78).

Conclusions

This study shows a significant inverse association between PTH and hemoglobin levels across the whole spectrum of non-dialysis CKD and a doubled risk of having serum hemoglobin <10.0 mg/dl in the absence of severely deranged PTH concentration. These findings may have clinical relevance in ascertaining the cause of unexplained low hemoglobin levels in CKD-patients.
Literature
2.
go back to reference Dunn CDR, Trent D (1981) The effect of parathyroid hormone on erythropoiesis in serum free cultures of fetal mouse liver cells. Proc Soc Exp Biol Med 166:556–561CrossRefPubMed Dunn CDR, Trent D (1981) The effect of parathyroid hormone on erythropoiesis in serum free cultures of fetal mouse liver cells. Proc Soc Exp Biol Med 166:556–561CrossRefPubMed
3.
go back to reference Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, Smith J (1982) Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69:1017–1025PubMedCentralCrossRefPubMed Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, Smith J (1982) Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69:1017–1025PubMedCentralCrossRefPubMed
4.
go back to reference Goicoechea M, Gomez-Campdera F, Polo JR, Tejedor A, Ruiz MA, Vazquez I, Verde E, Valderrabano F (1996) Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy. Clin Nephrol 45:420–421PubMed Goicoechea M, Gomez-Campdera F, Polo JR, Tejedor A, Ruiz MA, Vazquez I, Verde E, Valderrabano F (1996) Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy. Clin Nephrol 45:420–421PubMed
5.
go back to reference Zingraff J, Drueke T, Marie P, Man NK, Jungers P, Bordier P (1978) Anemia and secondary hyperparathyroidism. Arch Intern Med 138:1650–1652CrossRefPubMed Zingraff J, Drueke T, Marie P, Man NK, Jungers P, Bordier P (1978) Anemia and secondary hyperparathyroidism. Arch Intern Med 138:1650–1652CrossRefPubMed
6.
go back to reference Barbour GL (1979) Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med 139:889–891CrossRefPubMed Barbour GL (1979) Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med 139:889–891CrossRefPubMed
7.
go back to reference Mandolfo S, Malberti F, Farina M, Villa G, Scanziani R, Surian M, Imbasciati E (1998) Parathyroidectomy and response to erythropoietin therapy in anaemic patients with chronic renal failure. Nephrol Dial Transplant 13:2708–2709CrossRefPubMed Mandolfo S, Malberti F, Farina M, Villa G, Scanziani R, Surian M, Imbasciati E (1998) Parathyroidectomy and response to erythropoietin therapy in anaemic patients with chronic renal failure. Nephrol Dial Transplant 13:2708–2709CrossRefPubMed
8.
go back to reference Urena P, Eckardt KU, Sarfati E, Zingraff J, Zins B, Roullet JB, Roland E, Drueke T, Kurtz A (1991) Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy. Nephron 59:384–393CrossRefPubMed Urena P, Eckardt KU, Sarfati E, Zingraff J, Zins B, Roullet JB, Roland E, Drueke T, Kurtz A (1991) Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy. Nephron 59:384–393CrossRefPubMed
9.
go back to reference Brancaccio D, Cozzolino M, Gallieni M (2004) Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. J Am Soc Nephrol 15:21–24CrossRef Brancaccio D, Cozzolino M, Gallieni M (2004) Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. J Am Soc Nephrol 15:21–24CrossRef
10.
go back to reference Gallieni M, Corsi C, Brancaccio D (2000) Hyperparathyroidism and anemia in renal failure. Am J Nephrol 20:89–96CrossRefPubMed Gallieni M, Corsi C, Brancaccio D (2000) Hyperparathyroidism and anemia in renal failure. Am J Nephrol 20:89–96CrossRefPubMed
11.
go back to reference Sudhaker Rao D, Shih MS, Mohini R (1993) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171–175CrossRef Sudhaker Rao D, Shih MS, Mohini R (1993) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171–175CrossRef
12.
go back to reference Capuano A, Serio V, Pota A, Memoli B, Andreucci VE (2009) Beneficial effects of better control of secondary hyperparathyroidism with paracalcitol in chronic dialysis patients. J Nephrol 22:59–68PubMed Capuano A, Serio V, Pota A, Memoli B, Andreucci VE (2009) Beneficial effects of better control of secondary hyperparathyroidism with paracalcitol in chronic dialysis patients. J Nephrol 22:59–68PubMed
13.
go back to reference KDIGO (2012) Clinical practice guideline for anemia in chronic kidney disease. Kidney Int 2:1–64CrossRef KDIGO (2012) Clinical practice guideline for anemia in chronic kidney disease. Kidney Int 2:1–64CrossRef
14.
go back to reference Locatelli F, Zoccali C (2008) Clinical policies on the management of chronic kidney disease patients in Italy. Nephrol Dial Transplant 23:621–626CrossRefPubMed Locatelli F, Zoccali C (2008) Clinical policies on the management of chronic kidney disease patients in Italy. Nephrol Dial Transplant 23:621–626CrossRefPubMed
15.
go back to reference KDOQI (2007) KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50:471–530 KDOQI (2007) KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50:471–530
16.
go back to reference Minutolo R, Conte G, Cianciaruso B, Bellizzi V, Camocardi A, De Paola L, De Nicola L (2012) Hypo-responsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. Nephrol Dial Transplant 27:2880–2886CrossRefPubMed Minutolo R, Conte G, Cianciaruso B, Bellizzi V, Camocardi A, De Paola L, De Nicola L (2012) Hypo-responsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. Nephrol Dial Transplant 27:2880–2886CrossRefPubMed
17.
go back to reference Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W (2013) Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: European renal best practice position statement. Nephrol Dial Transplant 28:1346–1359CrossRefPubMed Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W (2013) Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: European renal best practice position statement. Nephrol Dial Transplant 28:1346–1359CrossRefPubMed
18.
go back to reference Hsu C-Y, McCulloch CE, Curhan GC (2002) Epidemiology of Anemia Associated with Chronic Renal Insufficiency among Adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13:504–510CrossRefPubMed Hsu C-Y, McCulloch CE, Curhan GC (2002) Epidemiology of Anemia Associated with Chronic Renal Insufficiency among Adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13:504–510CrossRefPubMed
19.
go back to reference El-Achkar TM, Ohmit SE, Mc Cullough AP, Crook ED, Brown WW, Grimm R, Bakris GL, Keane WF, Flack JM (2005) Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: the Kidney Early Evaluation Program. Kidney Int 67:1483–1488CrossRefPubMed El-Achkar TM, Ohmit SE, Mc Cullough AP, Crook ED, Brown WW, Grimm R, Bakris GL, Keane WF, Flack JM (2005) Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: the Kidney Early Evaluation Program. Kidney Int 67:1483–1488CrossRefPubMed
20.
go back to reference Li Vecchi M, Fuiano G, Marino F, Mancuso D, Faga T, Spontoni A, Provenzano R, Andreucci M, tozzo C (2005) Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degree of chronic renal insufficiency. Nephron Clin Pract 105:62–67CrossRef Li Vecchi M, Fuiano G, Marino F, Mancuso D, Faga T, Spontoni A, Provenzano R, Andreucci M, tozzo C (2005) Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degree of chronic renal insufficiency. Nephron Clin Pract 105:62–67CrossRef
21.
go back to reference Memon I, Norris KC, Bomback AS, Peralta C, Li S, Chen SC, McCullough PA, Whaley-Connell A, Jurkovitz C, Tamura MK, Saab G (2013) The association between parathyroid hormone levels and hemoglobin in diabetic and nondiabetic participants in the National Kidney Foundation’s kidney early evaluation program. Cardiorenal Med 3:120–127PubMedCentralCrossRefPubMed Memon I, Norris KC, Bomback AS, Peralta C, Li S, Chen SC, McCullough PA, Whaley-Connell A, Jurkovitz C, Tamura MK, Saab G (2013) The association between parathyroid hormone levels and hemoglobin in diabetic and nondiabetic participants in the National Kidney Foundation’s kidney early evaluation program. Cardiorenal Med 3:120–127PubMedCentralCrossRefPubMed
22.
go back to reference Patel NM, Gutierrez MO, Andress DL, Coyne DW, Levin A, Wolf M (2010) Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 77:715–720CrossRefPubMed Patel NM, Gutierrez MO, Andress DL, Coyne DW, Levin A, Wolf M (2010) Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 77:715–720CrossRefPubMed
Metadata
Title
Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease
Authors
Domenico Russo
Luigi Morrone
Biagio Di Iorio
Michele Andreucci
Maria Grazia De Gregorio
Carmela Errichiello
Luigi Russo
Francesco Locatelli
Publication date
01-12-2015
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 6/2015
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-014-0129-1

Other articles of this Issue 6/2015

Journal of Nephrology 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.